
Overview
Medapp is a company that develops 3D imaging technology and artificial intelligence for the medical field, specifically through its product CarnaLife Holo, which has received FDA certification. The company participates in medical technology exhibitions and collaborates with leading hospitals, such as the Medical University of Warsaw, for advanced medical procedures like heart ablation.
Financials
Revenue history (in k)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 194 days for 2020). All were audited by a statutory auditor.
- 202522/10/2026
- 202410/07/2025
- 202309/08/2024
- 202208/01/2024
- 202111/07/2022
- 202027/04/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Stock quotes
- Open
- PLN 0.17
- High
- PLN 0.17
- Low
- PLN 0.17
- Volume
- 31.11K
- Avg. vol.
- 16.02K
- Market cap
- PLN 41.52M
- P/E ratio
- –
- EPS
- -PLN 0.01
- Shares outstanding
- 250.13M
- 52-week
- PLN 0.17 – 0.18
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLYLWHT00012
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q3 2026 | USD 276.61k | USD -210.97k | USD -220.42k |
| Q2 2026 | USD 819.56k | USD 302.54k | USD 291.46k |
| Q1 2026 | USD 798.22k | USD 139.38k | USD 131.82k |
| Q4 2025 | USD 203.16k | USD 132.60k | USD -22.60k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical imaging software
- CT and MRI image visualization
- Anatomical holograms
- Surgical navigation system
Websites
- medapp.plHome Page
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| carnalife | Feb 17, 2027 | |
| medapp mobile medical aplications (word) | – | |
| medapp mobile medical aplications | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, declarations of will on behalf of the company must be made by two members of the management board acting jointly, or by two commercial proxies. In the case of a one-person management board, the sole member of the management board is independently authorized to make declarations of will on behalf of the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-11-26.
52 1090 2590 0000 0001 5568 2218
64 1090 2590 0000 0001 5568 2099
92 1090 2590 0000 0001 5568 2274
Debt
3 active proceedings recorded in KRZ.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Jan 27, 2026 | Accelerated arrangement proceedings | In progress | |
| Dec 29, 2025 | Petition to open accelerated arrangement proceedings | Closed | |
| Nov 19, 2025 | Petition to declare entrepreneur bankruptcy | Closed |
Public aid
22 public aid cases recorded, with a total value of $1,587,532.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 7, 2023 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Aug 14, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
4 EU budget awards (FTS) recorded, totalling $1,441,013.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2024-10-01 | We are health champions - disrupting the european healthcare systems with virtual reality and augmented reality applications | $677.6K$677,600 | 2.1.11 - European Regional Development Fund (ERDF) | |
| 2024-01-01 | End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants | $229.2K$229,204 | 1.0.11 - Horizon Europe | |
| 2024-01-01 | End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants | $15,672$15,672 | 1.0.11 - Horizon Europe |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Shapespark sp. z o.o. | $659,417.56 | shapespark.com | ||
| Medi.Com sp. z o.o. | $558,658.71 | medi.com.pl | ||
| Holo Vectors sp. z o.o. | $402,603.11 | holovectors.com | ||
| IQ Med sp. z o.o. | $301,729.42 | iq-med.pl | ||
| Pergamonmed sp. z o.o. | $296,205.09 | pergamonmed.pl | ||
| RSQ Technologies sp. z o.o. | $162,481.52 | rsqtechnologies.com | ||
| Radpal sp. z o.o. | $127,275.98 | radpal.pl | ||
| RSQ Holo sp. z o.o. | $113,118.26 | rsqholo.com | ||
| Apps4med sp. z o.o. | $68,254.41 | apps4med.pl | ||
| Idocly sp. z o.o. | $49,591.94 | hicora.ai |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-18 | Address change (Armii Krajowej 25, 30-150, Kraków → Aleja Juliusza Słowackiego 6/10, 30-037, Kraków) | |
| 2022-06-24 | Share capital increase (25,003,220.40 PLN → 25,013,245.40 PLN) | |
| 2021-07-28 | Address change (Aleja Płk. Władysława Beliny-Prażmowskiego 60, 31-514, Kraków → Armii Krajowej 25, 30-150, Kraków) | |
| 2021-07-08 | Share capital increase (24,716,094.00 PLN → 25,003,220.40 PLN) | |
| 2020-12-01 | Share capital increase (23,919,094.30 PLN → 24,716,094.00 PLN) |
FAQ
Last updated: 2026-10-22